Suspension of trading
Oncternal Therapeutics, Inc. Share Price
Stocks
ONCT
US68236P2065
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5266 USD | -24.11% |
|
-.--% | - |
| 01/25/01 | Oncternal Therapeutics, Inc. Appoints Craig R. Jalbert as CEO | CI |
| 01/25/01 | Oncternal Therapeutics, Inc. Announces Management Changes | CI |
| Market Cap | 15.59L 13.69L 12.73L 11.68L 21.95L 15Cr 22.29L 1.51Cr 59.06L 7.38Cr 58.51L 57.25L 26Cr | P/E 2022 |
-1.19x | P/E 2023 | -0.8x |
|---|---|---|---|---|---|
| Enterprise Value | -3.24Cr -2.84Cr -2.64Cr -2.43Cr -4.56Cr -311.81Cr -4.63Cr -31Cr -12Cr -153.3Cr -12Cr -12Cr -530.02Cr | EV / Sales 2022 |
-4.9x | EV / Sales 2023 | -2.95x |
| Free-Float |
90.77% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 day | -24.11% |
| 3 years | 0.53 |  | 13.14 |
| 5 years | 0.53 | | 92.6 |
| 10 years | 0.53 | | 211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Vincent
DFI | Director of Finance/CFO | 63 | 01/04/2017 |
Yisrael Katz
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/2023 |
Rajesh Krishnan
CTO | Chief Tech/Sci/R&D Officer | 53 | - |
| Director | Title | Age | Since |
|---|---|---|---|
David Hale
CHM | Chairman | 77 | 01/12/2018 |
Dan Kisner
BRD | Director/Board Member | 79 | 07/06/2019 |
William LaRue
BRD | Director/Board Member | 75 | 01/12/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 20/06/24 | Free | Director | 2,200 | 0.0743% | ||
| 20/06/24 | Free | Director | 2,200 | 0.0743% | ||
| 20/06/24 | Free | Director | 2,200 | 0.0743% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -24.11% | -.--% | -.--% | -93.42% | 15.59L | |
| +1.07% | -3.49% | -3.35% | +11.75% | 4.69TCr | |
| +0.25% | +1.65% | +399.22% | +647.65% | 4.02TCr | |
| -0.27% | +4.45% | +11.81% | +60.81% | 3.62TCr | |
| +0.35% | +0.87% | +4.46% | -10.31% | 3.47TCr | |
| +3.14% | +1.02% | +4.76% | +43.00% | 2.79TCr | |
| -0.73% | +11.84% | +34.39% | +134.44% | 1.68TCr | |
| +0.47% | -2.74% | - | - | 1.67TCr | |
| +0.42% | -5.52% | -3.43% | +9.10% | 1.31TCr | |
| -2.68% | -2.49% | -11.36% | -34.51% | 1.27TCr | |
| Average | -2.21% | -1.84% | +48.50% | +85.39% | 2.45TCr | |
| Weighted average by Cap. | +0.48% | +0.91% | +74.42% | +138.21% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 14.9L 13.09L 12.17L 11.17L 20.98L 14Cr 21.31L 1.45Cr 56.46L 7.05Cr 55.93L 54.73L 24Cr | 8L 7L 6L 6L 11.06L 7.56Cr 11.23L 76.14L 29.75L 3.72Cr 29.47L 28.83L 13Cr |
| Net income | -4.42Cr -3.88Cr -3.61Cr -3.31Cr -6.22Cr -425.36Cr -6.32Cr -43Cr -17Cr -209.12Cr -17Cr -16Cr -723.05Cr | -3.95Cr -3.47Cr -3.22Cr -2.96Cr -5.56Cr -380.19Cr -5.65Cr -38Cr -15Cr -186.91Cr -15Cr -15Cr -646.26Cr |
| Net Debt | -6.36Cr -5.59Cr -5.2Cr -4.77Cr -8.96Cr -612.83Cr -9.1Cr -62Cr -24Cr -301.29Cr -24Cr -23Cr -1.04TCr | -3.39Cr -2.98Cr -2.77Cr -2.54Cr -4.78Cr -326.82Cr -4.85Cr -33Cr -13Cr -160.67Cr -13Cr -12Cr -555.54Cr |
Employees
29
- Stock Market
- Stocks
- ONCT Stock
Select your edition
All financial news and data tailored to specific country editions
